How I treat refractory immune thrombocytopenia
Author:
Affiliation:
1. Department of Medicine and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and
2. Department of Pediatrics, Columbia University, New York, NY
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/128/12/1547/1395845/1547.pdf
Reference100 articles.
1. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review.;Vesely;Ann Intern Med,2004
2. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.;Rodeghiero;Blood,2009
3. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.;Neunert;Blood,2011
4. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.;Kojouri;Blood,2004
5. Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review.;Mikhael;Am J Hematol,2009
Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China;British Journal of Haematology;2024-06-03
2. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial;Signal Transduction and Targeted Therapy;2024-04-23
3. Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data;Current Medical Research and Opinion;2024-03-25
4. Evaluation of the hematological inflammatory parameters in the patients with immune thrombocytopenic purpura: A case–control study;Health Science Reports;2024-02
5. Risk‐based and individualised management of bleeding and thrombotic events in adults with primary immune thrombocytopenia (ITP);European Journal of Haematology;2023-12-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3